Latest news
24-10-2024 - Merck's 2025 Biopharma Innovation Cup Opens Soon for Applications
As the biopharmaceutical division of the German company Merck KGaA, Merck discovers, develops, manufactures and markets prescription medicines of both chemical and biological origin in specialist indications to help patients with cancer, multiple sclerosis, infertility, endocrine and metabolic disorders as well as cardiovascular diseases.
[...]